Aarkstore -TGR5 Receptor Agonists -Pipeline Insights, 2014

1
TGR5 Receptor Agonists -Pipeline Insights, 2014
Category Pharmaceuticals Healthcare

• Browse Complete Report -
• http//www.aarkstore.com/pharmaceuticals-healthcar
  e/76037/tgr5-receptor-agonists-pipeline-insights-2
  014

2
Summary

• DelveInsights,TGR5 Receptor Agonists-Pipeline
  Insights, 2014, report provides comprehensive
  insights about pipeline drugs across this
  mechanism of action (MOA). A key objective of the
  report is to establish the understanding for all
  the pipeline drugs that fall under TGR5 Receptor
  Agonists. This report provides information on the
  therapeutic development based on the TGR5
  Receptor Agonists dealing with mechanism of
  action, comparative analysis at various stages
  covering Filed, Phase III, Phase II, Phase I, IND
  filed, Preclinical, Discovery and unknown stages,
  therapeutics assessment by monotherapy and
  combination products and molecule type drug
  information. The report also covers the companies
  information involved in the therapeutic
  development of the products. It also has
  highlighted the discontinued and dormant products.

3
Summary

• Data Sources
• The report is built using data and information
  sourced from proprietary databases, primary and
  secondary research and in-house analysis by
  DelveInsight team of industry experts.Secondary
  sources information and data has been collected
  from various printable and non-printable sources
  like search engines, News websites, Government
  Websites, Trade Journals, White papers,
  Magazines, Trade associations, Books, Industry
  Portals, Industry Associations and access to
  available databases.Please note this report
  requires certain updates. We have all the
  information available but require 3 business days
  to complete the process and ensure it is as
  up-to-date as possible. Certain sections in the
  report may be removed or altered based on the
  availability and relevance of data for the
  indicated mechanism of action. 

4
Summary

• Scope 
• The report provides a snapshot of the global
  therapeutic landscape of TGR5 Receptor
  AgonistsThe report provides pipeline products
  under drug profile section which includes product
  description, MOA, licensors collaborators,
  development partner and chemical
  informationCoverage of the TGR5 Receptor
  Agonists pipeline on the basis of target, MOA,
  route of administration, technology involved and
  molecule typeThe report reviews key players
  involved in the therapeutics development for TGR5
  Receptor Agonists and also provide company
  profilingThe report also gives the information
  of dormant and discontinued pipeline
  projects Pipeline products coverage based on
  various stages of development ranging from
  preregistration till discovery and undisclosed
  stages Provides pipeline assessment by
  monotherapy and combination therapy products,
  stage of development and molecule type

5
Summary

• Reasons to buyComplete MOA intelligence and
  complete understanding over therapeutics
  development for TGR5 Receptor AgonistsIdentify
  the relationship between the drugs and use it for
  target finding, drug repurposing, and precision
  medicine.Devise corrective measures for pipeline
  projects by understanding TGR5 Receptor Agonists
  pipeline depth and focus of Indication
  therapeutics Developing strategic initiatives to
  support your drug development activities.Optimize
  your portfolio and keep you in touch with the
  rapidly changing pharmaceutical markets, and make
  the best decisions for your business.

6
Summary

• Develop and design in licensing and out licensing
  strategies by identifying prospective partners
  with the most attractive projects to enhance and
  expand business potential and ScopeProvides
  strategically significant competitor information,
  analysis, and insights to formulate effective RD
  development strategies Modify the therapeutic
  portfolio by identifying discontinued projects
  and understanding the factors that drove them
  from pipelineGaining a Full Picture of the
  Competitive Landscape for Evidence based Decisions

7
Table of Content

• TGR5 Receptor Agonists OverviewTGR5 Receptor
  Agonists Disease AssociatedTGR5 Receptor
  Agonists Pipeline TherapeuticsTGR5 Receptor
  Agonists Therapeutics under Development by
  Companies TGR5 Receptor Agonists Late Stage
  Products (Filed and Phase III)Comparative
  Analysis TGR5 Receptor Agonists Mid Clinical
  Stage Products (Phase II)Comparative
  Analysis TGR5 Receptor Agonists Early Clinical
  Stage Products (Phase I and IND
  Filed)Comparative Analysis TGR5 Receptor
  Agonists Discovery and Pre-Clinical Stage
  Products Comparative Analysis Drug Candidate
  Profiles

8
Table of Content

• TGR5 Receptor Agonists Therapeutics
  Assessment Assessment by Monotherapy
  Products Assessment by Combination
  Products Assessment by Route of
  Administration Assessment by Molecule Type TGR5
  Receptor Agonists Discontinued Products TGR5
  Receptor Agonists Dormant ProductsCompanies
  Involved in Therapeutics Development for TGR5
  Receptor Agonists Appendix Methodology Contact
  Us Disclaimer

9
List of Tables

• Number of Products under Development for TGR5
  Receptor Agonists by Therapy Area, 2014Number of
  Products under Development for TGR5 Receptor
  Agonists, 2014Number of Products under
  Development by Companies Comparative Analysis by
  Late Clinical Stage Products (Filed and Phase
  III), 2014Comparative Analysis Mid Clinical
  Stage Products (Phase II), 2014Comparative
  Analysis Early Clinical Stage Products (Phase I
  and IND Filed), 2014Comparative Analysis
  Discovery and Pre-Clinical Stage Products,
  2014Drug Candidates Profiles

10
List of Tables

• TGR5 Receptor Agonists Assessment by Monotherapy
  Products TGR5 Receptor Agonists Assessment by
  Combination Products TGR5 Receptor Agonists
  Assessment by Route of Administration TGR5
  Receptor Agonists Assessment by Stage and Route
  of Administration TGR5 Receptor Agonists
  Assessment by Molecule Type TGR5 Receptor
  Agonists Assessment by Stage and Molecule
  Type TGR5 Receptor Agonists Therapeutics
  Discontinued Products TGR5 Receptor Agonists
  Therapeutics Dormant ProductsProducts under
  Development by Companies, 2014

11
List of Figures

• Number of Products under Development for TGR5
  Receptor Agonists by Therapy Area, 2014Number of
  Products under Development for TGR5 Receptor
  Agonists, 2014Late Clinical Stage Products
  (Filed and Phase III), 2014Mid Clinical Stage
  Products (Phase II), 2014Early Clinical Stage
  Products (Phase I and IND Filed), 2014Discovery
  and Pre-Clinical Stage Products, 2014TGR5
  Receptor Agonists Assessment by Monotherapy
  Products TGR5 Receptor Agonists Assessment by
  Combination Products TGR5 Receptor Agonists
  Assessment by Route of Administration TGR5
  Receptor Agonists Assessment by Stage and Route
  of Administration TGR5 Receptor Agonists
  Assessment by Molecule Type TGR5 Receptor
  Agonists Assessment by Stage and Molecule
  TypeMolecule Type

12
Related Reports

• 2015 Worldwide Medical Laboratories
  Industry-Industry Market Report
• 2015 Worldwide Pharmaceutical Preparation Mfg.
  Industry-Industry Market Report
• OncoPlex Diagnostics - Pharmaceuticals
  Healthcare - Deals and Alliances Profile
• MetaStat, Inc. - Pharmaceuticals Healthcare -
  Deals and Alliances Profile
• Advanced Cell Diagnostics, Inc. - Pharmaceuticals
  Healthcare - Deals and Alliances Profile
• Ascension Health - Pharmaceuticals Healthcare -
  Deals and Alliances Profile
• Accretive Health, Inc. (ACHI) - Strategic SWOT
  Analysis Review
• Jazz Pharmaceuticals plc (JAZZ) - Financial and
  Strategic SWOT Analysis Review
• Pharmstandard (PHST) - Financial and Strategic
  SWOT Analysis Review
• GLG Life Tech Corporation (GLG) - Financial and
  Strategic SWOT Analysis Review

13

• TGR5 Receptor Agonists -Pipeline Insights, 2014
• Published Dec. 2014 60 Pages
• DelveInsights,TGR5 Receptor Agonists-Pipeline
  Insights, 2014, report provides comprehensive
  insights about pipeline drugs across this
  mechanism of action (MOA).
  Price

Format Price
PDF 1250
Site Licence 2500
Enterprise Wide Licence 4000
14
Contact Us
Office Office No. - 809, 8th Floor,B-Wing,
Mahaavir Icon, Plot No.- 89 90,
Sector-15,CBD-Belapur, Navi Mumbai
400614, Maharashtra, India. Telefax No 91 22
4127 6660 24/7 Online Support 91
9987295242 General Inquiries 91 - 22 2756 4953

• You Can Visit http//www.aarkstore.com
• OR Mail us at contact_at_aarkstore.com
• Blog
• http//www.aarkstore.com/blog/
• Conference
• http//conference.aarkstore.com/
• News
• http//www.aarkstore.com/news